Mirtazapine for the Treatment of Chronic Pruritus
AbstractBackground: Chronic pruritus is a debilitating condition associated with a wide range of dermatologic, systemic and psychogenic etiologies. In patients with chronic pruritus that is refractory to conventional therapy, symptoms can significantly decrease quality of life by contributing to anxiety, sleep disturbances, and in many cases depression. Recent studies have demonstrated the effectiveness of mirtazapine in relieving chronic itch that is refractory to standard first-line therapies. Methods: We searched PubMed for English-language articles containing the words (“pruritus” or “itch”) AND “antidepressant” and then conducted a systematic review of the current literature to summarize the efficacy of mirtazapine in treating chronic itch. Results: All studies reported a reduction in itch intensity following the administration of mirtazapine. Conclusion: Collectively, these studies suggest the potential for mirtazapine to relieve chronic itch attributed to dermatological causes and malignancies. As, such mirtazapine may be an option for patients with chronic pruritus that is refractory to typical first-line treatments. View Full-Text
Share & Cite This Article
Khanna, R.; Boozalis, E.; Belzberg, M.; Zampella, J.G.; Kwatra, S.G. Mirtazapine for the Treatment of Chronic Pruritus. Medicines 2019, 6, 73.
Khanna R, Boozalis E, Belzberg M, Zampella JG, Kwatra SG. Mirtazapine for the Treatment of Chronic Pruritus. Medicines. 2019; 6(3):73.Chicago/Turabian Style
Khanna, Raveena; Boozalis, Emily; Belzberg, Micah; Zampella, John G.; Kwatra, Shawn G. 2019. "Mirtazapine for the Treatment of Chronic Pruritus." Medicines 6, no. 3: 73.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.